Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aptinyx Inc | APTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.04 | 1.27% | 3.20 | 3.32 | 3.15 | 3.17 | 3.16 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.14 | 4.65 | 2.51 | 53.98% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 520 | 41,332 | $ 3.23 | $ 133,554 | 99,583 | 2.61 - 26.74 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:03 | 1 | $ 3.20 | USD |
Aptinyx Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 107.73M | 33.66M | $ -53.28M | -2.79 | - | 32.31M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 8.00 | 4.00% |
Aptinyx News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical APTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.35 | 3.50 | 3.10 | 3.30 | 70,082 | -0.15 | -4.48% |
| 1 Month | 3.00 | 3.62 | 2.90 | 3.22 | 75,429 | 0.20 | 6.67% |
| 3 Months | 3.25 | 4.25 | 2.61 | 3.40 | 101,026 | -0.05 | -1.54% |
| 6 Months | 3.48 | 4.89 | 2.61 | 3.40 | 150,015 | -0.28 | -8.05% |
| 1 Year | 23.45 | 26.74 | 2.61 | 5.59 | 242,823 | -20.25 | -86.35% |
| 3 Years | 17.40 | 32.25 | 2.61 | 9.27 | 214,894 | -14.20 | -81.61% |
| 5 Years | 17.40 | 32.25 | 2.61 | 9.27 | 214,894 | -14.20 | -81.61% |
Aptinyx Description
| Aptinyx Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel, proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. Its pipeline products are NYX-2925, NYX-458, and NYX-783. NYX-2925 is a novel, oral, small-molecule NMDA receptor modulator in clinical development as a therapy for chronic pain. NYX-2925 works by enhancing synaptic plasticity, a mechanism uniquely suited to addressing chronic pain, and NYX-783 is an NMDA receptor modulating small molecule in clinical development as a therapy for post-traumatic stress disorder. |
